ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Consun Pharmaceutical Group Ltd (PK)

Consun Pharmaceutical Group Ltd (PK) (CPHGF)

1,65
0,00
( 0,00% )
Mis à jour : 19:33:15

Consun Pharmaceutical Group Ltd (PK) (CPHGF) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
1,65
( - )
Prix Achat
1,26
Prix Vente
2,26
Volume échangé
-
0,00 Fourchette du Jour 0,00
1,12 Plage de 52 semaines 2,00
Cap du marché
Clôture Veille
1,65
Ouverture
-
Dernière Transaction
Dernière heure de transaction
-
Volume financier
-
VWAP
-
Volume moyen (3 m)
US$ 1 973 463
Actions en circulation
841 547 111
Rendement du Dividende (LTM)
0,66
Ratio Cours sur Bénéfices
9,89
Bénéfice par action (BPA)
1,26
Chiffre d'affairess (LTM)
3,42B
Bénéfice net (LTM)
1,08B

À propos de Consun Pharmaceutical Group Ltd (PK)

Consun Pharmaceutical Group Limited, together with its subsidiaries, produces and sells pharmaceutical products in Mainland China. It operates through two segments, Consun Pharmaceutical and Yulin Pharmaceutical. The company offers uremic clearance granules for chronic renal failure; Yishen Huashi p... Consun Pharmaceutical Group Limited, together with its subsidiaries, produces and sells pharmaceutical products in Mainland China. It operates through two segments, Consun Pharmaceutical and Yulin Pharmaceutical. The company offers uremic clearance granules for chronic renal failure; Yishen Huashi particles for proteinuria; TCM to treat diabetic kidney disease; Gadopentetate Dimeglumine injections for nervous centralis, stomach, chest, pelvic cavity, and extremities, as well as for renal function assessment; Iopamidol injections for neuroradiology, angiography, and urography; and ultrasonic microbubble contrast agent products. It also provides Yuanli Kang, an iron-dextrin oral solution; Yibao Yuan, an erythromycin estolate suspension; Yuantong Ning, a cetirizine hydrochloride oral solution; Zhixueling capsules to treat hysteromyoma bleeding, prolonged lochiorrhea, intermenstrual bleeding, bleeding after use of a contraceptive ring, hemorrhoidal bleeding, and epistaxis; Gyn Antidysmenorrheic tablets for irregular menstruation, period during perimenopause, and abdominal pain during menstruation due to hepatic depression and blood deficiency; and Antibacterial Fujie lotion to treat staphylococcus aureus, candida albicans, and escherichia coli in the feminine vaginal. In addition, the company offers bone-setting liquid; Yunxiang analgesic tincture to treat rheumatism, common cold, headache, stomachache, cardiodynia, and pain in the gastral cavity and chilblain; Sanqi Chuangchun capsules for activating blood circulation and dispersing blood stasis; Shiduqing capsules and tablets, and Paeonol ointment for skin disease; hepatobiliary products, such as Jigucao, Compound Jigucao, and Qinggan tablets, as well as Jigucao Ganyan and Wujun Zhidan granules; and gastroenterology medicines, tonics, and other medicines. Consun Pharmaceutical Group Limited was founded in 1997 and is headquartered in Guangzhou, the People’s Republic of China. Show more

Secteur
Healthcare
Industrie
Pharmaceuticals
Site Web
Siège social
Guangzhou, China
Fondé
1997
Consun Pharmaceutical Group Ltd (PK) est coté dans le secteur Healthcare de la OTC Markets avec le ticker CPHGF. Le dernier cours de clôture d'Consun Pharmaceutical (PK) était de US$1,65. Au cours de la dernière année, les actions de Consun Pharmaceutical (PK) ont été négociées dans une fourchette de prix de US$ 1,12 à US$ 2,00.

Consun Pharmaceutical (PK) compte actuellement 841 547 111 actions en circulation. La capitalisation boursière d'Consun Pharmaceutical (PK) est de US$1,39 milliard. Consun Pharmaceutical (PK) a un ratio cours/bénéfice (ratio PE) de 9.89.

CPHGF Dernières nouvelles

Aucune actualité à afficher pour le moment.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
12001.651.651.6500CS
260.5347.32142857141.1221.121111.825CS
520.5347.32142857141.1221.12501.825CS
1560.606658.13686026451.043421.0434128701.04707568CS
2600.606658.13686026451.043421.0434128701.04707568CS

CPHGF - Frequently Asked Questions (FAQ)

What is the current Consun Pharmaceutical Group Ltd (PK) share price?
The current share price of Consun Pharmaceutical Group Ltd (PK) is US$ 1,65
How many Consun Pharmaceutical Group Ltd (PK) shares are in issue?
Consun Pharmaceutical Group Ltd (PK) has 841 547 111 shares in issue
What is the market cap of Consun Pharmaceutical Group Ltd (PK)?
The market capitalisation of Consun Pharmaceutical Group Ltd (PK) is USD 1,39B
What is the 1 year trading range for Consun Pharmaceutical Group Ltd (PK) share price?
Consun Pharmaceutical Group Ltd (PK) has traded in the range of US$ 1,12 to US$ 2,00 during the past year
What is the PE ratio of Consun Pharmaceutical Group Ltd (PK)?
The price to earnings ratio of Consun Pharmaceutical Group Ltd (PK) is 9,89
What is the cash to sales ratio of Consun Pharmaceutical Group Ltd (PK)?
The cash to sales ratio of Consun Pharmaceutical Group Ltd (PK) is 3,07
What is the registered address of Consun Pharmaceutical Group Ltd (PK)?
The registered address for Consun Pharmaceutical Group Ltd (PK) is 71, Dongpeng Avenue, Guangzhou, Guangdong Province
What is the Consun Pharmaceutical Group Ltd (PK) website address?
The website address for Consun Pharmaceutical Group Ltd (PK) is chinaconsun.com
Which industry sector does Consun Pharmaceutical Group Ltd (PK) operate in?
Consun Pharmaceutical Group Ltd (PK) operates in the Pharmaceuticals sector

CPHGF Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion